Breaking News
Get 40% Off 0
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did. Read how
Close

Cytokinetics Inc (CYTK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Cytokinetics Inc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
62.10 -1.92    -3.00%
16:00:59 - Closed. Currency in USD ( Disclaimer )
After Hours
62.00
-0.10
-0.16%
19:58:07 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,342,020
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 61.25 - 64.61
Cytokinetics Inc 62.10 -1.92 -3.00%

NASDAQ:CYTK Financials

 
A brief overview of the NASDAQ:CYTK financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Cytokinetics over time.

Cytokinetics, Incorporated reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 0.835 million compared to USD 4.61 million a year ago. Net loss was USD 135.64 million compared to USD 131.29 million a year ago. Basic loss per share from continuing operations was USD 1.33 compared to USD 1.38 a year ago. Diluted loss per share from continuing operations was USD 1.33 compared to USD 1.38 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

CYTK Income Statement

Gross margin TTM -8,755.86%
Operating margin TTM -13,272.04%
Net Profit margin TTM -14,141.74%
Return on Investment TTM 0%
 Total Revenue  Net Income
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Revenue 1.67 0.378 0.867
Gross Profit -80.74 -83.3 -82.15 -82.33
Operating Income -127.42 -122.26 -122.05
Net Income -136.9 -129.42 -128.64

CYTK Balance Sheet

Quick Ratio MRQ 6.98
Current Ratio MRQ 7.19
LT Debt to Equity MRQ 0%
Total Debt to Equity MRQ -190.56%
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Assets 824.32 740.61 779.9
Total Liabilities 1210.64 1179.42 1113.01
Total Equity -386.32 -438.8 -333.12

CYTK Cash Flow Statement

Cash Flow/Share TTM -4.02
Revenue/Share TTM 0.04
Operating Cash Flow  -
 Cash  Net Change in Cash
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -74.04 -96.2 -121.8
Cash From Investing Activities -81.41 73.04 82.13
Cash From Financing Activities 168.8 54.22 5.48
Net Change in Cash 13.33 31.05 -34.2
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CYTK Comments

Write your thoughts about Cytokinetics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Kabeer gupta
Kabeer gupta Dec 29, 2021 9:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Riped for the correction. let's watch next few weeks.
Dr Sultan Usman Adam
DrSultan Jul 19, 2021 2:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Life Clips, Inc has skyrocketed roughly 3061% over the last two days after it announced a pivot into blockchain.
Paul Lavin
Paul Lavin Jul 19, 2021 10:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
10 dollar jump today now $29.35 from $20.
Dr Sultan Usman Adam
DrSultan Jul 19, 2021 10:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yeah I saw it
Dr Sultan Usman Adam
DrSultan Jul 19, 2021 10:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Life Clips, Inc has skyrocketed roughly 3061% over the last two days after it announced a pivot into blockchain.
Kabeer gupta
Kabeer gupta Nov 11, 2020 11:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
20 soon.
João Manzoli
j_manzoli Oct 15, 2020 11:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is it worth continuing with this stock?
Farhad Ahmad
Farhad Ahmad Oct 08, 2020 5:33PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Soon it will be reaching 3 months moving average $20+
Rafa AR
Rafa AR Oct 08, 2020 10:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Different than other biopharma companies, they have a large portfolio. Bad news for short, an opportunity for long.
Dav San
Dav San Oct 08, 2020 10:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think there will be a bounce in the next days but do you think it's gonna go down more?
Charlie Yacklon
Charlie Yacklon Oct 08, 2020 10:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sure if they can make some positive progress in their trials moving forward
Charlie Yacklon
Charlie Yacklon Oct 08, 2020 10:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sure if they can make some positive progress in their trials moving forward
Marc Wilson
Marc Wilson Oct 08, 2020 9:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will this pop back up?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email